174 related articles for article (PubMed ID: 22776956)
1. Cannabinoid receptor activation correlates with the proapoptotic action of the β2-adrenergic agonist (R,R')-4-methoxy-1-naphthylfenoterol in HepG2 hepatocarcinoma cells.
Paul RK; Ramamoorthy A; Scheers J; Wersto RP; Toll L; Jimenez L; Bernier M; Wainer IW
J Pharmacol Exp Ther; 2012 Oct; 343(1):157-66. PubMed ID: 22776956
[TBL] [Abstract][Full Text] [Related]
2. Activation of β2-adrenergic receptor by (R,R')-4'-methoxy-1-naphthylfenoterol inhibits proliferation and motility of melanoma cells.
Wnorowski A; Sadowska M; Paul RK; Singh NS; Boguszewska-Czubara A; Jimenez L; Abdelmohsen K; Toll L; Jozwiak K; Bernier M; Wainer IW
Cell Signal; 2015 May; 27(5):997-1007. PubMed ID: 25703025
[TBL] [Abstract][Full Text] [Related]
3. Concurrent activation of β
Wnorowski A; Such J; Paul RK; Wersto RP; Indig FE; Jozwiak K; Bernier M; Wainer IW
Cell Signal; 2017 Aug; 36():176-188. PubMed ID: 28495590
[TBL] [Abstract][Full Text] [Related]
4. (R,R')-4'-methoxy-1-naphthylfenoterol targets GPR55-mediated ligand internalization and impairs cancer cell motility.
Paul RK; Wnorowski A; Gonzalez-Mariscal I; Nayak SK; Pajak K; Moaddel R; Indig FE; Bernier M; Wainer IW
Biochem Pharmacol; 2014 Feb; 87(4):547-61. PubMed ID: 24355564
[TBL] [Abstract][Full Text] [Related]
5. {Beta}2-adrenergic receptor agonists inhibit the proliferation of 1321N1 astrocytoma cells.
Toll L; Jimenez L; Waleh N; Jozwiak K; Woo AY; Xiao RP; Bernier M; Wainer IW
J Pharmacol Exp Ther; 2011 Feb; 336(2):524-32. PubMed ID: 21071556
[TBL] [Abstract][Full Text] [Related]
6. GPR55 receptor antagonist decreases glycolytic activity in PANC-1 pancreatic cancer cell line and tumor xenografts.
Bernier M; Catazaro J; Singh NS; Wnorowski A; Boguszewska-Czubara A; Jozwiak K; Powers R; Wainer IW
Int J Cancer; 2017 Nov; 141(10):2131-2142. PubMed ID: 28741686
[TBL] [Abstract][Full Text] [Related]
7. Heterodimerization With 5-HT
Song Y; Xu C; Liu J; Li Y; Wang H; Shan D; Wainer IW; Hu X; Zhang Y; Woo AY; Xiao RP
Circ Res; 2021 Jan; 128(2):262-277. PubMed ID: 33208036
[TBL] [Abstract][Full Text] [Related]
8. Deprogramming metabolism in pancreatic cancer with a bi-functional GPR55 inhibitor and biased β
Wnorowski A; Dudzik D; Bernier M; Wójcik J; Keijzers G; Diaz-Ruiz A; Mazur K; Zhang Y; Han H; Scheibye-Knudsen M; Jozwiak K; Barbas C; Wainer IW
Sci Rep; 2022 Mar; 12(1):3618. PubMed ID: 35256673
[TBL] [Abstract][Full Text] [Related]
9. Effect of fenoterol stereochemistry on the β2 adrenergic receptor system: ligand-directed chiral recognition.
Jozwiak K; Plazinska A; Toll L; Jimenez L; Woo AY; Xiao RP; Wainer IW
Chirality; 2011; 23 Suppl 1(Suppl 1):E1-6. PubMed ID: 21618615
[TBL] [Abstract][Full Text] [Related]
10. Antitumor activity of (R,R')-4-methoxy-1-naphthylfenoterol in a rat C6 glioma xenograft model in the mouse.
Bernier M; Paul RK; Dossou KS; Wnorowski A; Ramamoorthy A; Paris A; Moaddel R; Cloix JF; Wainer IW
Pharmacol Res Perspect; 2013 Dec; 1(2):e00010. PubMed ID: 25505565
[TBL] [Abstract][Full Text] [Related]
11. Agonist-specific activation of the beta2-adrenoceptor/Gs-protein and beta2-adrenoceptor/Gi-protein pathway in adult rat ventricular cardiomyocytes.
Pönicke K; Gröner F; Heinroth-Hoffmann I; Brodde OE
Br J Pharmacol; 2006 Apr; 147(7):714-9. PubMed ID: 16474418
[TBL] [Abstract][Full Text] [Related]
12. Selective GPR55 antagonism reduces chemoresistance in cancer cells.
Singh NS; Bernier M; Wainer IW
Pharmacol Res; 2016 Sep; 111():757-766. PubMed ID: 27423937
[TBL] [Abstract][Full Text] [Related]
13. Tyrosine 308 is necessary for ligand-directed Gs protein-biased signaling of β2-adrenoceptor.
Woo AY; Jozwiak K; Toll L; Tanga MJ; Kozocas JA; Jimenez L; Huang Y; Song Y; Plazinska A; Pajak K; Paul RK; Bernier M; Wainer IW; Xiao RP
J Biol Chem; 2014 Jul; 289(28):19351-63. PubMed ID: 24831005
[TBL] [Abstract][Full Text] [Related]
14. Thermodynamics and docking of agonists to the β(2)-adrenoceptor determined using [(3)H](R,R')-4-methoxyfenoterol as the marker ligand.
Toll L; Pajak K; Plazinska A; Jozwiak K; Jimenez L; Kozocas JA; Tanga MJ; Bupp JE; Wainer IW
Mol Pharmacol; 2012 Jun; 81(6):846-54. PubMed ID: 22434858
[TBL] [Abstract][Full Text] [Related]
15. Comparative molecular field analysis of the binding of the stereoisomers of fenoterol and fenoterol derivatives to the beta2 adrenergic receptor.
Jozwiak K; Khalid C; Tanga MJ; Berzetei-Gurske I; Jimenez L; Kozocas JA; Woo A; Zhu W; Xiao RP; Abernethy DR; Wainer IW
J Med Chem; 2007 Jun; 50(12):2903-15. PubMed ID: 17506540
[TBL] [Abstract][Full Text] [Related]
16. Molecular interactions between fenoterol stereoisomers and derivatives and the β₂-adrenergic receptor binding site studied by docking and molecular dynamics simulations.
Plazinska A; Kolinski M; Wainer IW; Jozwiak K
J Mol Model; 2013 Nov; 19(11):4919-30. PubMed ID: 24043542
[TBL] [Abstract][Full Text] [Related]
17. Anti-inflammatory activities of fenoterol through β-arrestin-2 and inhibition of AMPK and NF-κB activation in AICAR-induced THP-1 cells.
Wang W; Chen J; Li XG; Xu J
Biomed Pharmacother; 2016 Dec; 84():185-190. PubMed ID: 27657826
[TBL] [Abstract][Full Text] [Related]
18. Contribution of the extracellular cAMP-adenosine pathway to dual coupling of β2-adrenoceptors to Gs and Gi proteins in mouse skeletal muscle.
Duarte T; Menezes-Rodrigues FS; Godinho RO
J Pharmacol Exp Ther; 2012 Jun; 341(3):820-8. PubMed ID: 22438472
[TBL] [Abstract][Full Text] [Related]
19. Interaction of fenoterol stereoisomers with β2-adrenoceptor-G sα fusion proteins: antagonist and agonist competition binding.
Reinartz MT; Kälble S; Wainer IW; Seifert R
Naunyn Schmiedebergs Arch Pharmacol; 2015 May; 388(5):517-24. PubMed ID: 25637582
[TBL] [Abstract][Full Text] [Related]
20. The mitogenic effectors of isoproterenol in human hepatocellular carcinoma cells.
Yuan A; Li Z; Li X; Yi S; Wang S; Cai Y; Cao H
Oncol Rep; 2010 Jan; 23(1):151-7. PubMed ID: 19956875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
